HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website – founded as a partnership between CHDI and the Coppola Lab at UCLA – is currently a joint development effort by CHDI, Bridlewood Consulting and Rancho BioSciences. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
| Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- HDBuzz Is Officially Independent: What This Means, and Why It Matters
- 2025: Year in Review
- Break Up With Your CAGs: How Three Letters Could Change Huntington’s Disease
- First participants dosed in new POINT-HD huntingtin-lowering trial
- A road less traveled: how making less huntingtin can alter somatic instability and may delay symptoms
News
- Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self ...
- Researchers Use Computational Methods to Identify Predictive Biomarkers for Tailored ...
- Pharma Industry Advances in Digital Technologies and Complex Molecule Development in 2025
- AI and Label-Free Imaging Technology Enhance Precision in Thyroid Cancer Surgery
- Trump Urges GOP to Show Flexibility on Abortion Restrictions to Advance Health Care Negotiations




